Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Peregrine Pharmaceuticals begins phase III trial of bavituximab

Jan. 2, 2014

OncoTherapy Science stops phase III study of C-01 for pancreatic cancer

Dec. 27, 2013

NewLink Genetics begins phase I trial of HyperAcute Renal

Dec. 27, 2013

Cancer vaccine K562/GM-CSF evaluated in patients with myelodysplastic syndrome

Dec. 27, 2013

Cervarix two-dose schedule receives European marketing authorization

Dec. 24, 2013

Regulatory application filed for nivolumab in malignant melanoma

Dec. 24, 2013

California Stem Cell completes phase I stem cell trial for HCC

Dec. 23, 2013

Roche to study RO-6895882 in advanced and/or metastatic solid tumors

Dec. 23, 2013

GSK and Genmab receive FDA priority review for Arzerra BLA

Dec. 19, 2013

Chimeric antigen receptor therapy for pediatric ALL targets the TSLPR

Dec. 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...